Despite advancements in ventricular arrhythmia (VA) screening, numerous high-profile athlete cases have highlighted the need for improved detection and management. A new study presented at Heart Rhythm 2025 in April evaluated the connection between complex VA patterns in athletes and underlying structural heart disease, offering critical insights into the prognostic value of both non-invasive and invasive assessments in athletes with complex VAs.
Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work from anywhere at any time.

Available from Core Sound Imaging, Studycast provides an intuitive workflow from viewing images to creating reports to archiving exams. Its cloud-based system puts a comprehensive imaging workflow at your fingertips from any browser.

June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This prospective, multi-center randomized controlled trial enrolled 100 patients to evaluate computer assisted vacuum thrombectomy (CAVT) using Penumbra’s Lightning Flash plus anticoagulation, versus anticoagulation alone, for the treatment of acute intermediate-high risk pulmonary embolism (PE).

June 13, 2025 — An international study has shown that targeted online education on atrial fibrillation (AF) for health professionals can improve guideline-adherent care. 

June 11, 2025 — MorningStar Laboratories, LLC, a developer of precision diagnostic tests that address unmet clinical needs, has announced its SmartVascular Dx (SVDx) test (formally known as the PULS Cardiac test), designed to transform the early detection and management of vascular health, empowering healthcare providers to implement proactive strategies that significantly enhance patient outcomes.

June 04, 2025 —  HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough Device designation for its Aortic Stenosis (“AS”) ECG algorithm.

Aortic Stenosis is one of the most serious and common heart valve diseases, often progressing silently and leading to severe, life-threatening outcomes if left undetected. Early symptoms are frequently vague or absent, resulting in delayed diagnosis and treatment. If unrecognized, AS can cause irreversible myocardial damage and significant deterioration in cardiac function.

June 12, 2025 — Viz.ai recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural Plus, the first and only comprehensive solution for quantifying the size of collections like subdural hemorrhages (SDH) in the subdural space on non-contrast computed tomography (NCCT) images. The Viz Subdural Plus module is designed to support clinical-decision making by automatically labeling subdural collections and reporting measurements, including volume, thickness, and midline shift. 

June 12, 2025 – The American Society of Echocardiography (ASE) and Cardiovascular Research Foundation (CRF) have announced a new educational collaboration to foster shared learning, drive innovation and strengthen connections across the cardiovascular community.

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with MIM Encore, marking a significant milestone in its mission to deliver precision care through advanced digital solutions.

This implementation brings powerful new features to healthcare organizations using GE HealthCare systems alongside MIM software with MIM Encore, a single platform design based on user input to help enhance diagnostic confidence, streamline workflows and support the future of personalized medicine.

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an additional five years, to further advance findings in human genomics research in cardiovascular diseases. The expanded agreement will focus on joint precision cardiology target identification, leveraging the established human cardiomyocyte platform to rapidly validate observations, and discovery of novel therapeutic approaches.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now